K-numberK243036
Device nameIPL Hair Removal Device (BHRL-01, BHRL-02, BHRL-03, BHRL-04, BHRL-05, BHRL-06, BHRL-06B, BHRL-07, BHRL-08, BHRL-09, BHRL-10, BHRL-11, BHRL-12, BHRL-13, BHRL-14, BHRL-15, BHRL-16, BHRL-17, BHRL-18, BHRL-19, BHRL-20, BHRL-21, BHRL-22, BHRL-23, BHRL-24, BHRL-25, BHRL-26, BHRL-27, BHRL-28, BHRL-29)
ApplicantBestway Plastic and Metal Products , Ltd.
Product codeOHT
Device classClass II
Decision dateJun 15, 2025
DecisionSubstantially Equivalent
Regulation878.4810
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The IPL Hair Removal Device is an over-the-counter, home-use device that uses Intense Pulsed Light (IPL) technology to remove unwanted hair and provide permanent reduction in hair regrowth, measured at 6, 9, and 12 months after treatment completion. The device operates via finger-switch activation and includes a skin sensor to detect proper skin contact; most models also include a cooling function.

Technological characteristics

The subject device uses a xenon arc lamp IPL source with wavelength range 510–1200±15 nm, energy density 1.2–4.1 J/cm², output energy 4.5–10 J (±20%), and spot sizes of either 3.6±0.25 cm² or 2.7±0.25 cm² depending on model. It incorporates microprocessor control, operates on 100–240V 50/60Hz power, and requires no sterilization. Key differences from the predicate include varied dimensions across 23 models and a 5-level intensity control.

Test standards cited

Biocompatibility per ISO 10993-1; electrical safety and EMC per IEC 60601-1, IEC 60601-1-2, IEC 60601-1-11, and IEC 60601-2-83; eye safety per IEC 62471; software verification and validation per basic documentation level; usability per FDA's February 2016 guidance on human factors.

Substantial equivalence argument

The device shares identical intended use (unwanted hair removal and permanent reduction in regrowth), same light-based mechanism of action (IPL technology), identical light source (xenon arc lamp), same general wavelength range, similar energy density and output parameters, and equivalent safety standards (electrical, optical, biocompatibility) with the legally-marketed predicate device K230739. Minor dimensional and control-level variations do not raise safety or efficacy concerns given substantially similar technical performance and non-clinical test results demonstrating equivalent safety and effectiveness.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →